Lilly CEO Ricks Advocates Rebalancing Drug Pricing Between US And Europe

Adopting EU Price Controls Stateside ‘Worst Of Two Worlds’

 
• By Mandy Jackson
  
Lilly is discussing ideas with the Trump administration for rebalancing US and European drug prices (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip